Celgene Corporation is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. Our talent, scientific knowledge and research capabilities help us to deliver access to innovative, disease-altering therapies to those who need them most. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies. Celgene is headquartered in Summit, New Jersey, and employs more than 7,000 people located in more than 60 countries. For more information, please visit the Company's website at www.celgene.com. Before joining the discussion, please read Celgene's community guidelines on LinkedIn:
Celgene
Venture CapitalCelgene Corporation is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.
38
Total Investments
28
Portfolio Companies
-
Exits
3
Industries
General Information
Company Overview
Investment Criteria
•••••• •••••• ••••••
About Celgene
Recent Investments (38)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Debt Financing | •••••• | May 2021 | |
| Series D | •••••• | Jan 2020 | |
| Series F | •••••• | Sep 2019 | |
| Series B | •••••• | Aug 2019 | |
| Series C | •••••• | Aug 2019 | |
|
|
Series D | •••••• | Jul 2019 |
|
|
Series B | •••••• | Apr 2019 |
|
|
Spinout | •••••• | Feb 2019 |
|
|
Series B | •••••• | Jan 2019 |
|
|
Series B | •••••• | Jan 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.